Parametric Portfolio Associates’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Parametric Portfolio Associates’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.49M	Buy	45,505 +28,043	+161%	+$832K	﹤0.01%	2574
2021 Q4	$460K	Sell	17,462 -34,726	-67%	-$2.69M	﹤0.01%	3109
2021 Q3	$5.25M	Sell	52,188 -9,294	-15%	-$1.09M	﹤0.01%	1793
2021 Q2	$8.7M	Buy	61,482 +8,346	+16%	+$942K	﹤0.01%	1488
2021 Q1	$5.3M	Buy	53,136 +2,733	+5%	+$319K	﹤0.01%	2124
2020 Q4	$6.23M	Buy	50,403 +30,006	+147%	+$3.94M	﹤0.01%	1925
2020 Q3	$1.99M	Sell	20,397 -3,354	-14%	-$419K	﹤0.01%	2509
2020 Q2	$3.71M	Buy	23,751 +1,650	+7%	+$251K	﹤0.01%	2093
2020 Q1	$3.19M	Sell	22,101 -5,564	-20%	-$1.07M	﹤0.01%	2065
2019 Q4	$5.66M	Buy	27,665 +9,390	+51%	+$1.71M	﹤0.01%	1968
2019 Q3	$1.47M	Sell	18,275 -13,428	-42%	-$1.14M	﹤0.01%	2818
2019 Q2	$2.99M	Buy	31,703 +1,318	+4%	+$114K	﹤0.01%	2385
2019 Q1	$2.6M	Buy	30,385 +9,616	+46%	+$798K	﹤0.01%	2492
2018 Q4	$1.17M	Buy	20,769 +955	+5%	+$58.3K	﹤0.01%	2888
2018 Q3	$1.62M	Buy	+19,814	New	+$1.4M	﹤0.01%	2846

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Parametric Portfolio Associates's RETA Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) stake by 161% in Q1 2022, buying an estimated $832K and bringing the position to 45,505 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2574.

Parametric Portfolio Associates first reported a position in RETA in Q3 2018 and has held it in 15 quarters since. The position peaked at $8.7M in Q2 2021. 149 funds tracked by Wall St. Rank hold RETA as of Q1 2022.

Parametric Portfolio Associates held 45,505 shares of Reata Pharmaceuticals, Inc. Class A Common Stock worth $1.49M as of Q1 2022.
Parametric Portfolio Associates bought 28,043 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2022, an estimated $832K.
Reata Pharmaceuticals, Inc. Class A Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2574 holding.
Parametric Portfolio Associates first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2018 and has held it in 15 quarters since.
Parametric Portfolio Associates's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $8.7M in Q2 2021.
149 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.